Proteomic features of colorectal cancer independently predict relapse-free survival.

被引：0
|
作者：
Clarke, Callisia [1 ]
Lee, Michael Sangmin [1 ]
Manyam, Ganiraju C. [1 ]
Jiang, Zhi-Qin [1 ]
Tian, Feng [1 ]
Lu, Yiling [1 ]
Morris, Jeffrey [1 ]
Broom, Bradley McIntosh [1 ]
Menter, David [1 ]
Sanchez, Eduardo Vilar [1 ]
Raghav, Kanwal Pratap Singh [1 ]
Eng, Cathy [1 ]
Chang, George J. [1 ]
Overman, Michael J. [1 ]
Maru, Dipen M. [1 ]
Kopetz, Scott [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
10.1200/jco.2015.33.3_suppl.616
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
616
引用
收藏
页数：1
相关论文
共 50 条
  • [41] SIGNIFICANCE OF GENE AMPLIFICATIONS ON RELAPSE-FREE SURVIVAL (RFS) AND OVERALL SURVIVAL (OS) IN METASTATIC BREAST CANCER
    Todorovic-Rakovic, Natasa
    Neskovic-Konstantinovic, Zora
    Nikolic-Vukosavljevic, Dragica
    [J]. BREAST, 2013, 22 : S59 - S60
  • [42] The preoperative kinetics of prostate- specific antigen as a predict of relapse-free survival after radical prostatectomy
    Bogomolov, O. A.
    Shkolnik, M. I.
    Zharinov, G. M.
    [J]. ONKOUROLOGIYA, 2014, 10 (04): : 47 - 51
  • [43] IMPROVED RELAPSE-FREE SURVIVAL IN MEDULLOBLASTOMA UTILIZING MODERN TECHNIQUES
    NORRIS, DG
    BRUCE, DA
    BYRD, RL
    SCHUT, L
    LITTMAN, P
    BILANIUK, LT
    ZIMMERMAN, RA
    CAPP, R
    [J]. NEUROSURGERY, 1981, 9 (06) : 661 - 664
  • [44] Relapse-free survival time bought with severe side effects
    Staar, S
    [J]. LARYNGO-RHINO-OTOLOGIE, 2005, 84 (06) : 396 - 397
  • [45] Capecitabine after surgery significantly increases relapse-free survival
    不详
    [J]. ONCOLOGY-NEW YORK, 2004, 18 (08): : 1077 - 1078
  • [46] Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer
    Bergsland, Christian H.
    Bruun, Jarle
    Guren, Marianne G.
    Svindland, Aud
    Bjornslett, Merete
    Smeby, Jorgen
    Hektoen, Merete
    Kolberg, Matthias
    Domingo, Enric
    Pellinen, Teijo
    Tomlinson, Ian
    Kerr, David
    Church, David N.
    Nesbakken, Arild
    Sveen, Anita
    Lothe, Ragnhild A.
    [J]. ESMO OPEN, 2020, 5 (06)
  • [47] Development of Relapse-Free Survival Classifiers in Glioblastoma Patients by Integrating Multiparametric Magnetic Resonance Imaging Features
    Grass, D.
    Chou, K.
    Zhang, G.
    Liveringhouse, C.
    Latif, K.
    Arrington, J.
    Moros, E.
    Yu, M.
    [J]. MEDICAL PHYSICS, 2018, 45 (06) : E453 - E453
  • [48] Germline INDELs and CNVs in a cohort of colorectal cancer patients: their characteristics, associations with relapse-free survival time, and potential time-varying effects on the risk of relapse
    Werdyani, Salem
    Yu, Yajun
    Skardasi, Georgia
    Xu, Jingxiong
    Shestopaloff, Konstantin
    Xu, Wei
    Dicks, Elizabeth
    Green, Jane
    Parfrey, Patrick
    Yilmaz, Yildiz E.
    Savas, Sevtap
    [J]. CANCER MEDICINE, 2017, 6 (06): : 1220 - 1232
  • [49] Evaluating relapse-free survival as an endpoint for overall survival in adjuvant immunotherapy trials
    Li, Yuanfang
    Yuan, Shuqiang
    Chen, Yingbo
    Nie, Man
    Li, Jibin
    Chen, Guoming
    Chen, Xiaojiang
    Zhang, Ruopeng
    Zheng, Ziqi
    Wei, Chengzhi
    Zhou, Zhiwei
    Nie, Runcong
    Wang, Yun
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (09) : 1085 - 1091
  • [50] A competing risks cure frailty model: An application to relapse-free survival of breast cancer patients
    Ghavami, Vahid
    Mahmoudi, Mahmood
    Foroushani, Abbas Rahimi
    Baghishani, Hossein
    Yaseri, Mehdi
    Shandiz, Fatemeh Homaei
    [J]. PAKISTAN JOURNAL OF STATISTICS AND OPERATION RESEARCH, 2021, 17 (03) : 591 - 605
12345